Press Releases

All Releases
Yield10 Bioscience Announces Warrant Exercises for Proceeds of $3.8 million
February 19, 2021
WOBURN, Mass. , Feb. 19, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced that it has received proceeds of approximately $3.8 million from the exercise of 472,099 warrants exercised between January 1, 2021 and February 16, 2021 ,
Yield10 Bioscience Announces Closing of $12.7 Million Public Offering
February 3, 2021
WOBURN, Mass. , Feb. 03, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the closing of its previously announced underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per
Yield10 Bioscience Announces Pricing of $12.7 Million Public Offering
January 31, 2021
WOBURN, Mass. , Jan. 31, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced the pricing of its underwritten public offering of 1,040,000 shares of its common stock at a public offering price of $12.25 per share.
Yield10 Bioscience Announces Proposed Public Offering of Common Stock
January 29, 2021
WOBURN, Mass. , Jan. 29, 2021 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today announced it has commenced an underwritten public offering of shares of its common stock. The public offering is subject to market conditions, and there can be no
Yield10 Bioscience Announces Third Quarter 2020 Financial Results
November 12, 2020
WOBURN, Mass. , Nov. 12, 2020 (GLOBE NEWSWIRE) -- Yield10 Bioscience, Inc. (Nasdaq: YTEN ), an agricultural bioscience company, today reported financial results for the three and nine months ended September 30, 2020 . "We are very pleased with our strong progress across multiple fronts in the third
Displaying 1 - 20 of 90